previous arrow
next arrow
Slider
Product Image
A sterile, aqueous colloidal solution of Vitamin K1

Category: Vitamins

Species: Cattle, Sheep, Pigs, Goats, Horses, Dogs, Cats

Active Ingredients: (phytonadione)

prescription required

What is Veta-K1® Injection

VETA-K1® Injection is a yellow, sterile, aqueous colloidal solution of Vitamin K1, with a pH of 5.0 to 7.0, available for injection by intravenous, intramuscular, and subcutaneous routes.

Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Indications

Veta-K1® Injection is indicated in coagulation disorders which are due to faulty formation of factors II, VII, IX and X when caused by vitamin K deficiency or interference with vitamin K activity.

Veta-K1® Injection is indicated in cattle, calves, horses, swine, sheep, goats, dogs, and cats to counter hypoprothrombinemia induced by ingestion of anticoagulant rodenticides.

Veta-K1® Injection is also indicated to counter hypoprothrombinemia caused by consumption of bishydroxycoumarin found in spoiled and moldy sweet clover.

Benefits

Veta-K1® Injection contains Phytonadione for the treatment of acute hypoprothrombinemia (with hemorrhage) in cats, dogs, cattle, calves, horses, swine, sheep and goats.

  • Natural
    Solution possesses the same type and degree of activity as naturally occurring vitamin K.
  • Start-up Therapy
    Veta-K1® Injections are used to begin treatment in a critical care situation or hospitalization. (Follow injection therapy with Veta-K1® oral capsules.)
  • Stimulation of Prothrombin
    Vitamin K stimulates the production via the liver of active prothrombin from a precursor protein.
  • Efficacious
    Drug-induced hypoprothrombinemia responds to interference with vitamin K metabolism.
  • Safe
    Phytonadione will not counteract other therapy such as anticoagulant action of heparin.

Additional Safety Information

  • Severe reactions, including fatalities, have occurred during and immediately after intravenous injection of phytonadione.  IV route should be restricted to those situations where other routes are not feasible and the serious risk involved is considered justified.
  • Temporary resistance to prothrombin-depressing anticoagulants may result, especially when larger doses of phytonadione are used.
  • Repeated large doses of vitamin K are not warranted in liver disease if the response to initial use of the vitamin is unsatisfactory.
  • Pain, swelling and tenderness at the injection site may occur.
  • IM injection may result in hematomas.

Pack Size

List No.Pack SizeCase Size
1VIT015100 mL12